This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
11/25/15 - 9:41:38 AM ET (BATS BZX Real-time Price)
Div Yield: --
DEPO Day's Range
DEPO 52 Week Range
DEPO Business Summary
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States.View DEPO key stats
DepoMed Inc - DEPO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates DepoMed Inc as a
Hold with a ratings score of C+.
Report Snippet: We rate DEPOMED INC (DEPO) a HOLD. The primary factors that have impacted our rating are mixed – some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, generally higher debt management risk and disappointing return on equity.